For people with kidney failure, home dialysis can offer more freedom and better quality of life. So what’s stopping the NHS ...

Jaden Christopher has been celebrating the 50th anniversary of the hit movie "Jaws." He got to feed sharks in Florida and jump off a bridge from the movie in Martha's Vineyard. It has been a good year ...

She is among many patients now asking why, with no apparent change in their blood test results, chronic kidney disease (CKD) is suddenly appearing as a problem on their medical charts. The answer is ...

On 16 October 2024, KitNewCare will host its Innovation Challenge, an event designed to foster collaborative innovation towards achieving sustainability in kidney care.

From biased diagnostic tools to unequal access to treatment options, health care inequality is an issue in the United States. The system has failed Black Americans at every step of kidney disease.

Vantive is investing $1bn towards advancing its kidney care and vital organ support proposition. The company, which was formerly Baxter’s kidney care unit, becoming Vantive after being spun out ...

Baxter’s sale of the kidney care business was part of a three-pronged strategy, announced by the company in 2023, to strengthen and transform the company.

Focusing on self-care can help you manage chronic kidney disease. Try these self-care tips.

Baxter International is selling its kidney care segment to Carlyle Group for $3.8 billion, most of which will be paid in cash.

New insights into the biology of kidney cancer, including those informed by scientific discoveries that earned a Nobel Prize, have led to advances in treatment and increased survival rates.

NEW YORK (Reuters) -Buyout firm Carlyle Group struck a deal to acquire Baxter’s kidney-care unit Vantive for $3.8 billion, the companies said on Tuesday.

Global investment firm Carlyle will acquire Baxter’s kidney care segment — the soon-to-be-named Vantive — for $3.8 billion, the company announced Tuesday morning. As part of the investment, Carlyle is ...